Cisneros Discloses CRNX Sale Days Before Insider Sale Filing
Rep. Gilbert Cisneros has filed a Periodic Transaction Report with the U.S. House of Representatives disclosing the sale of common stock in Crinetics Pharmaceuticals, Inc. (CRNX). The transaction, dated July 30, 2026, was made by the member of Congress personally and falls within the disclosed amount range of $15,001 to $50,000. The filing lists the … Read more